Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „substrate“
Suchtreffer
Begriffe & Kennungen
Degarelix Accord · 4.5 · Degarelix is not a substrate for the human CYP450 system and has not been shown to induce or inhibit CYP1A2, C
Eintrag öffnenDelstrigo · 4.5 · However, co-administration of doravirine and the sensitive CYP3A substrate midazolam resulted in a 18 % decrea
Eintrag öffnenDelta-Catenin
Eintrag öffnenDiacomit · 4.5 · Co-administration with CYP3A4 substrates with a narrow therapeutic index should be avoided due to the markedly
Eintrag öffnenDiacomit · 4.5 · Co-administration with CYP3A4 substrates with a narrow therapeutic index should be avoided due to the markedly
Eintrag öffnenDiacomit · 4.5 · Co-administration with CYP3A4 substrates with a narrow therapeutic index should be avoided due to the markedly
Eintrag öffnenDiacomit · 4.5 · Co-administration with CYP3A4 substrates with a narrow therapeutic index should be avoided due to the markedly
Eintrag öffnenDificlir · 4.5 · Effect of fidaxomicin on P-gp substrates
Eintrag öffnenDificlir · 4.5 · Effect of fidaxomicin on P-gp substrates
Eintrag öffnenDificlir · 4.5 · Fidaxomicin does not have a clinically significant effect on the exposure of rosuvastatin, a substrate for the
Eintrag öffnenDificlir · 4.5 · Fidaxomicin does not have a clinically significant effect on the exposure of rosuvastatin, a substrate for the
Eintrag öffnenDificlir · 4.5 · Fidaxomicin is a substrate of P-gp. Co-administration of single doses of the P-gp inhibitor cyclosporine A and
Eintrag öffnenDificlir · 4.5 · Fidaxomicin is a substrate of P-gp. Co-administration of single doses of the P-gp inhibitor cyclosporine A and
Eintrag öffnenDovato · 4.3 · Co-administration with medicinal products with narrow therapeutic windows, that are substrates of organic cati
Eintrag öffnenDovato · 4.5 · Although lamivudine is a substrate of BCRP and P-gp in vitro, given its high absolute bioavailability, (see se
Eintrag öffnenDovprela (previously Pretomanid FGK) · 4.5 · Effect on CYP2C8, 2C9 and 2C19 substrates In vitro studies show that pretomanid is an inducer of CYP2C8 while
Eintrag öffnenDovprela (previously Pretomanid FGK) · 4.5 · Effect on OAT3, OATP1B3, P-gp and BCRP substrates Pretomanid is an inhibitor of the OAT3 transporter in vitro,
Eintrag öffnenDuloxetine Zentiva · 4.5 · Medicinal products metabolised by CYP1A2 The pharmacokinetics of theophylline, a CYP1A2 substrate, were not si
Eintrag öffnenDynastat · 4.5 · 7 Coadministration of valdecoxib with glibenclamide (CYP3A4 substrate) did not affect either the pharmacokinet
Eintrag öffnenDynastat · 4.5 · Coadministration of valdecoxib with glibenclamide (CYP3A4 substrate) did not affect either the pharmacokinetic
Eintrag öffnen